Evidence map›Paper›PMID 40159284›Full record

ArticleJournal of clinical and experimental hematopathology : JCEH2025

Long-term remission in a patient with NK/T cell intravascular lymphoma with autologous hematopoietic cell transplantation.

Hiroki Tsutsumi, Keisuke Tanaka, Atsushi Hamamura, Norihiko Nakamura, Shigeo Toyota

Abstract readCase Reports
In one paragraph

Article in Journal of clinical and experimental hematopathology : JCEH, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hiroki TsutsumiYokosuka Kyosai Hospital, Kanagawa, Japan.
Keisuke TanakaYokosuka Kyosai Hospital, Kanagawa, Japan.
Atsushi HamamuraYokosuka Kyosai Hospital, Kanagawa, Japan.
Norihiko NakamuraYokosuka Kyosai Hospital, Kanagawa, Japan.
Shigeo ToyotaYokosuka Kyosai Hospital, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intravascular lymphoma (IVL) is a rare subtype of lymphoma, mostly of B-cell origin. A few cases of IVL have been reported as having NK/T cell origins (IVNKTL). These cases are known to be fatal, especially when systemic symptoms are present. We report the case of a patient of IVNKTL who was refractory to initial treatment and received autologous hematopoietic stem cell transplantation (auto-HSCT). She has maintained complete remission (CR) for over eight years. Our case might support the evidence of auto-HSCT for the treatment of IVNKTL with chemosensitivity.

Indexed as

Hematopoietic Stem Cell TransplantationLymphoma, Extranodal NK-T-CellVascular NeoplasmsFemaleHumansMiddle AgedRemission InductionTransplantation, Autologoushematopoietic stem cell transplantationintravascular lymphomaintravascular NK/T cell lymphoma

Identifiers

PMID40159284
PMCPMC12051424

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.